The Impact of Microbiome Dysbiosis on Disease Pathogenesis and Therapeutic Approaches

Abstract

The human microbiome, a complex community of microorganisms inhabiting various body

sites, plays a crucial role in maintaining health. Microbiome dysbiosis, which refers to an

imbalance in the microbial communities, has been implicated in the pathogenesis of a range

of diseases, including inflammatory bowel disease (IBD), metabolic disorders, autoimmune

conditions, and neurodegenerative diseases. This paper explores the mechanisms by which

microbiome dysbiosis influences disease progression, focusing on gut microbiota's

interaction with the immune system and metabolic pathways. Furthermore, it reviews current

therapeutic strategies aimed at restoring microbial balance, including probiotics, prebiotics,

antibiotics, fecal microbiota transplantation, and personalized medicine approaches. The

evolving understanding of the microbiome's role in disease underscores the need for targeted

therapies that consider the microbiome's composition as part of a holistic treatment strategy.